Insider · CIK 0001247024
Gilla Kaplan
Files at AVTX (Avalo Therapeutics, Inc.), TYRA (Tyra Biosciences, Inc.). First filing Jun 16, 2025, latest Jun 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TYRA: Tyra Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | TYRAsell Tyra Biosciences, Inc. | $94k 9,578 shares | -25% | +36% from low-66% from high | |
| 53Moderate | TYRAsell Tyra Biosciences, Inc. | $535k 51,814 shares | -58% | +46% from low-64% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stock | -10 | $10.35 | $104 | 37,799 | Jun 20, 2025 |
| Jun 18, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stock | -9,568 | $9.78 | $94k | 28,231 | Jun 20, 2025 |
| Jun 17, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,100 | $0.00 | $0 | 20,100 | Jun 18, 2025 |
| Jun 12, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stock | -30,000 | $10.31 | $309k | 59,623 | Jun 16, 2025 |
| Jun 13, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stock | -15,000 | $10.31 | $155k | 44,623 | Jun 16, 2025 |
| Jun 16, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stock | -6,814 | $10.38 | $71k | 37,809 | Jun 16, 2025 |
| May 29, 2025 | TYRA Tyra Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,200 | $0.00 | $0 | 22,200 | Jun 2, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock | +3,167 | - | - | 3,167 | Apr 1, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,167 | $0.00 | $0 | 6,333 | Apr 1, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.